HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stable cell growth arrest that is characterized by the silencing of proliferation-promoting genes through compaction of chromosomes into senescence-associated heterochromatin foci (SAHF). Paradoxically, senescence is also accompanied by increased transcription of certain genes encoding for secreted factors such as cytokines and chemokines, known as the senescence-associated secretory phenotype (SASP). How SASP genes are excluded from SAHF-mediated global gene silencing remains unclear. In this study, we report that high mobility group box 2 (HMGB2) orchestrates the chromatin landscape of SASP gene loci. HMGB2 preferentially localizes to SASP gene loci during senescence. Loss of HMGB2 during senescence blunts SASP gene expression by allowing for spreading of repressive heterochromatin into SASP gene loci. This correlates with incorporation of SASP gene loci into SAHF. Our results establish HMGB2 as a novel master regulator that orchestrates SASP through prevention of heterochromatin spreading to allow for exclusion of SASP gene loci from a global heterochromatin environment during senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HMGB2 directly binds and specifically regulates SASP gene expression in oncogene-induced senescent cells, and its depletion diminishes SASP without affecting the senescence growth arrest108.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [108]
In the citing paper
“Among the high mobility group (HMG) family members, HMGB2 is a non-histone chromatin-binding protein that remodels the chromatin architecture and binds to the loci of key SASP genes. Then, HMGB2 prevents their incorporation into transcriptionally repressive heterochromatin regions, facilitating their expression [169].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 2×
“GSE38442), and reads were aligned to the human genome (version hg19) using Bowtie 2.2.5 (Langmead et al., 2009).”
InfluentialHeinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“ple t test, with nominal p-values corrected for multiple testing using published procedures (Storey and Tibshirani, 2003).”
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1×
“Oncogene-induced senescence is a bona fide tumor suppressor mechanism, whereas senescence caused by shortened telomeres (replicative senescence) is known to play a role in tissue aging (Campisi et al., 2011; Campisi, 2013).”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“Although the cell cycle arrest phenotype of senescence is tumor suppressive, the detrimental side effects of the SASP have tumor-promoting characteristics and may also play a role in tissue aging (Pérez-Mancera et al., 2014; van Deursen, 2014).”
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Other SASP regulators include NOTCH1 (160) and the high mobility group B proteins (HMGB1 and HMGB2) (7, 86).”
BackgroundSenescence and the SASP: many therapeutic avenues
Birch, J., & Gil, J. (2020) · Genes & Development · doi:10.1101/gad.343129.120 · Cited by 1,177
“Other epigenetic modifiers, such as histone–lysine–N-methyltransferase 2A (MLL1) and HMGB2 also favor SASP production by keeping their genetic loci in an open and active state (Aird et al. 2016; Capell et al. 2016).”
BackgroundUnmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863
The senescence-associated secretory phenotype and its physiological and pathological implications
Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00727-x · Cited by 948
The senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
Takahashi, A., Loo, T. M., Okada, R., Kamachi, F., Watanabe, Y., Wakita, M., Watanabe, S., Kawamoto, S., Miyata, K., Barber, G. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03555-8 · Cited by 350
Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium
Brighton, P. J., Maruyama, Y., Fishwick, K., Vrljicak, P., Tewary, S., Fujihara, R., Muter, J., Lucas, E. S., Yamada, T., Woods, L., et al. (2017) · eLife · doi:10.7554/elife.31274 · Cited by 323
Watanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321
Cellular senescence in development, regeneration and disease
Rhinn, M., Ritschka, B., & Keyes, W. M. (2019) · Development · doi:10.1242/dev.151837 · Cited by 279
Cuollo, L., Antonangeli, F., Santoni, A., & Soriani, A. (2020) · Biology · doi:10.3390/biology9120485 · Cited by 291
Zirkel, A., Nikolic, M., Sofiadis, K., Mallm, J.-P., Brackley, C. A., Gothe, H., Drechsel, O., Becker, C., Altmüller, J., Josipovic, N., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.030 · Cited by 226
Wiley, C. D., Flynn, J. M., Morrissey, C., Lebofsky, R., Shuga, J., Dong, X., Unger, M. A., Vijg, J., Melov, S., & Campisi, J. (2017) · Aging Cell · doi:10.1111/acel.12632 · Cited by 234
Strategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200
“The solution to this problem might come from new studies on epigenetic regulators, including mixed-lineage leukemia protein 1 (MLL1), bromodomain-containing protein 4 (BRD4), and high-mobility group box 2 (HMGB2), which are responsible for reshaping the epigenetic landscape of senescent cells in a manner that would di…”
BackgroundLiu, P., Li, F., Lin, J., Fukumoto, T., Nacarelli, T., Hao, X., Kossenkov, A. V., Simon, M. C., & Zhang, R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00656-3 · Cited by 182
Self-citationN6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance
Fukumoto, T., Zhu, H., Nacarelli, T., Karakashev, S., Fatkhutdinov, N., Wu, S., Liu, P., Kossenkov, A. V., Showe, L. C., Jean, S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3592 · Cited by 178
Self-citationBET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
Karakashev, S., Zhu, H., Yokoyama, Y., Zhao, B., Fatkhutdinov, N., Kossenkov, A. V., Wilson, A. J., Simpkins, F., Speicher, D., Khabele, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.095 · Cited by 174
Self-citationSenescence and the tumor-immune landscape: Implications for cancer immunotherapy
Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 161
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
Epigenetic Regulation of Cellular Senescence
Crouch, J., Shvedova, M., Thanapaul, R. J. R. S., Botchkarev, V., & Roh, D. (2022) · Cells · doi:10.3390/cells11040672 · Cited by 126
FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence
Macedo, J. C., Vaz, S., Bakker, B., Ribeiro, R., Bakker, P. L., Escandell, J. M., Ferreira, M. G., Medema, R., Foijer, F., & Logarinho, E. (2018) · Nature Communications · doi:10.1038/s41467-018-05258-6 · Cited by 131
A common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 135
The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies
Toutfaire, M., Bauwens, É., & Debacq‐Chainiaux, F. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.011 · Cited by 119
Chromatin basis of the senescence-associated secretory phenotype
Hao, X., Wang, C., & Zhang, R. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.12.003 · Cited by 94
Self-citationRibosome biogenesis restricts innate immune responses to virus infection and DNA
Bianco, C., & Mohr, I. (2019) · eLife · doi:10.7554/elife.49551 · Cited by 112
Rendeiro, A. F., Krausgruber, T., Fortelny, N., Zhao, F., Penz, T., Farlik, M., Schuster, L. C., Nemc, A., Tasnády, S., Réti, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14081-6 · Cited by 96
Taniguchi, N., Kawakami, Y., Maruyama, I., & Lotz, M. (2017) · Human Cell · doi:10.1007/s13577-017-0182-x · Cited by 101
Fairfield, H., Dudakovic, A., Khatib, C. M., Farrell, M., Costa, S., Falank, C., Hinge, M., Murphy, C. S., DeMambro, V., Pettitt, J. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1088 · Cited by 88
Dissecting primary and secondary senescence to enable new senotherapeutic strategies
Admasu, T. D., Rae, M. J., & Stolzing, A. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101412 · Cited by 102
Boyer, M. J., Kimura, Y., Akiyama, T. H., Baggett, A., Preston, K. J., Scalia, R. G., Eguchi, S., & Rizzo, V. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1781427 · Cited by 90
Suppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
Self-citationShort-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
The role of the dynamic epigenetic landscape in senescence: orchestrating SASP expression
Dasgupta, N., Arnold, R., Equey, A., Gandhi, A., & Adams, P. D. (2024) · npj Aging · doi:10.1038/s41514-024-00172-2 · Cited by 101
Genome homeostasis defects drive enlarged cells into senescence
Manohar, S., Estrada, M. E., Uliana, F., Vuina, K., Alvarez, P. M., de Bruin, R. A. M., & Neurohr, G. E. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.018 · Cited by 82
Giroud, J., Bouriez, I., Paulus, H., Pourtier, A., Debacq-Chainiaux, F., & Pluquet, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310788 · Cited by 73
Jing, Y., Jiang, X., Ji, Q., Wu, Z., Wang, W., Liu, Z., Guillen-Garcia, P., Esteban, C. R., Reddy, P., Horvath, S., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.09.007 · Cited by 73
The senescence journey in cancer immunoediting
Zingoni, A., Antonangeli, F., Sozzani, S., Santoni, A., Cippitelli, M., & Soriani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01973-5 · Cited by 84
Cellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 84
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Leon, K. E., Buj, R., Lesko, E., Dahl, E. S., Chen, C.-W., Tangudu, N. K., Imamura-Kawasawa, Y., Kossenkov, A. V., Hobbs, R. P., & Aird, K. M. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202008101 · Cited by 70
“However, SASP genes are protected from heterochromatinization via HMGB2 (Aird et al., 2016), allowing their continued and increased transcription.”
InfluentialSelf-citationPro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
Lessons from the Crypt: HMGA1—Amping up Wnt for Stem Cells and Tumor Progression
Resar, L. M. S., Chia, L., & Xian, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3045 · Cited by 74
Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence
Zhao, B., Liu, P., Fukumoto, T., Nacarelli, T., Fatkhutdinov, N., Wu, S., Lin, J., Aird, K. M., Tang, H.-Y., Liu, Q., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14652-y · Cited by 67
Self-citationStructure and Functions of HMGB2 Protein
Starkova, T. Y., Polyanichko, A. M., Tomilin, A. N., & Chikhirzhina, E. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098334 · Cited by 77
Epigenetic Basis of Cellular Senescence and Its Implications in Aging
Nacarelli, T., Liu, P., & Zhang, R. (2017) · Genes · doi:10.3390/genes8120343 · Cited by 63
Self-citationInteractions of HMGB Proteins with the Genome and the Impact on Disease
Voong, C. K., Goodrich, J. A., & Kugel, J. F. (2021) · Biomolecules · doi:10.3390/biom11101451 · Cited by 66
Iwasaki, O., Tanizawa, H., Kim, K.-D., Kossenkov, A., Nacarelli, T., Tashiro, S., Majumdar, S., Showe, L. C., Zhang, R., & Noma, K.-I. (2019) · Nature Communications · doi:10.1038/s41467-019-13604-5 · Cited by 58
Self-citationAlveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 61
Sun, X., & Feinberg, M. W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.693067 · Cited by 58
Mechanical confinement governs phenotypic plasticity in melanoma
Hunter, M. V., Joshi, E., Bowker, S., Montal, E. D., Ma, Y., Kim, Y. H., Yang, Z., Tuffery, L., Li, Z., Rosiek, E., et al. (2025) · Nature · doi:10.1038/s41586-025-09445-6 · Cited by 70
Xiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 66
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 61
Han, Q., Xu, L., Lin, W., Yao, X., Jiang, M., Zhou, R., Sun, X., & Zhao, L. (2018) · Oncogene · doi:10.1038/s41388-018-0614-4 · Cited by 56
Pancreatic β-cell senescence in diabetes: mechanisms, markers and therapies
Cha, J., Aguayo‐Mazzucato, C., & Thompson, P. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1212716 · Cited by 54
Cancer and Cardiovascular Disease
Alhuneafat, L., Guha, A., Blaes, A. H., & Konety, S. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.07.001 · Cited by 66
Nunes, C., Depestel, L., Mus, L. M., Keller, K. M., Delhaye, L., Louwagie, A., Rishfi, M., Whale, A. J., Kara, N., Andrews, S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn1382 · Cited by 54
A tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Dahl, E. S., Buj, R., Leon, K. E., Newell, J. M., Kawasawa, Y. I., Bitler, B. G., Snyder, N. W., & Aird, K. M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1233 · Cited by 50
Self-citationAtaxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
Self-citationThompson, P. J., Shah, A. N., Apostolopolou, C.-C., & Bhushan, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194776 · Cited by 47
Zhang, X., Dang, Y., Liu, R., Zhao, S., Ma, J., & Qin, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29725 · Cited by 44
Soluble factors influencing the neural stem cell niche in brain physiology, inflammation, and aging
Willis, C. M., Nicaise, A. M., Krzak, G., Ionescu, R.-B., Pappa, V., D’Angelo, A., Agarwal, R., Repollés-de-Dalmau, M., Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114124 · Cited by 48
The functional impact of nuclear reorganization in cellular senescence
Rocha, A., Dalgarno, A., & Neretti, N. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab012 · Cited by 38
Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target
Narasimhan, A., Flores, R. R., Camell, C. D., Bernlohr, D., Robbins, P. D., & Niedernhofer, L. J. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01493-w · Cited by 45
Chronic irradiation of human cells reduces histone levels and deregulates gene expression
Lowe, D., Herzog, M., Mosler, T., Cohen, H., Felton, S. J., Beli, P., Raj, K., Galanty, Y., & Jackson, S. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59163-4 · Cited by 44
Lee, J. Y., Yu, K.-R., Lee, B.-C., Kang, I., Kim, J.-J., Jung, E.-J., Kim, H.-S., Seo, Y., Choi, S. W., & Kang, K.-S. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0092-3 · Cited by 36
Zhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01604-7 · Cited by 35
“HMGB2 directly binds and precisely regulates the expression of the SASP gene in oncogene-induced senescent cells [36].”
BackgroundKimura, A., Matsuda, T., Sakai, A., Murao, N., & Nakashima, K. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24559 · Cited by 36
DNA G-Quadruplexes Contribute to CTCF Recruitment
Tikhonova, P., Pavlova, I., Isaakova, E. A., Цветков, В. Б., Bogomazova, A. N., Vedekhina, T., Luzhin, A. V., Sultanov, R., Severov, V. V., Klimina, K. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137090 · Cited by 35
Exploring cellular senescence in the musculoskeletal system: Any insights for biomarkers discovery?
Gerosa, L., Malvandi, A. M., Malavolta, M., Provinciali, M., & Lombardi, G. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101943 · Cited by 35
Latexin regulation by HMGB2 is required for hematopoietic stem cell maintenance
Zhang, C., Fondufe‐Mittendorf, Y. N., Wang, C., Chen, J., Cheng, Q. S., Zhou, D., Zheng, Y., Geiger, H., & Liang, Y. (2019) · Haematologica · doi:10.3324/haematol.2018.207092 · Cited by 29
Chen, K., Zhang, J., Liang, F., Zhu, Q., Cai, S., Tong, X., He, Z., Liu, X., Chen, Y., & Mo, D. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03959-3 · Cited by 31
HMGB2 holds the key to the senescence-associated secretory phenotype
Guerrero, A., & Gil, J. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201610044 · Cited by 30
Senolytic treatment alleviates doxorubicin‐induced chemobrain
Budamagunta, V., Kumar, A., Rani, A., Sindhu, S. M., Yang, Y., Zhou, D., & Foster, T. C. (2024) · Aging Cell · doi:10.1111/acel.14037 · Cited by 38
HIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs
Cohen, J., D’Agostino, L., Tuzer, F., & Torres, C. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.008 · Cited by 31
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Lawrence, I., Bene, M. R., Nacarelli, T., Azar, A., Cohen, J., Torres, C. A., Johannes, G. J., & Sell, C. (2018) · GeroScience · doi:10.1007/s11357-018-0015-1 · Cited by 31
Song, J., & Bae, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010406 · Cited by 32
Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System
Yeo, G. E. C., Ng, M. H., Nordin, F., & Law, J. X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115749 · Cited by 30
Senescence: An Identity Crisis Originating from Deep Within the Nucleus
Olan, I., & Narita, M. (2022) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-120420-013537 · Cited by 25
Cell enlargement modulated by GATA4 and YAP instructs the senescence-associated secretory phenotype
Joung, J., Heo, Y., Kim, Y., Kim, J., Choi, H., Jeon, T., Jang, Y., Kim, E.-J., Lee, S. H., Suh, J. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56929-0 · Cited by 29
Comparison of several commonly used detection indicators of cell senescence
Xiao, Y., Zhang, Y., & Xiao, F. (2018) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1551407 · Cited by 26
HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
Zheng, X., Lu, J., Liu, J., Zhou, L., & He, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115118 · Cited by 24
Therapeutic strategies targeting cellular senescence for cancer and other diseases
Wang, X., Fukumoto, T., & Noma, K.-I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae015 · Cited by 29
Self-citationBalamurli, G., Liew, A. Q. X., Tee, W., & Pervaiz, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103441 · Cited by 25
Al‐razaq, M. A. A., Freyter, B. M., Isermann, A., Tewary, G., Mangelinck, A., Mann, C., & Rübe, C. E. (2023) · Cells · doi:10.3390/cells12060916 · Cited by 24
HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles
Lee, D., Taniguchi, N., Sato, K., Choijookhuu, N., Hishikawa, Y., Kataoka, H., Morinaga, H., Lotz, M., & Chosa, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-28023-7 · Cited by 19
Yano, K., Choijookhuu, N., Ikenoue, M., Fidya, Fukaya, T., Sato, K., Lee, D., Taniguchi, N., Chosa, E., Nanashima, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16258-4 · Cited by 25
HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
Kučírek, M., Bagherpoor, A. J., Jaroš, J., Hampl, A., & Štros, M. (2019) · The FASEB Journal · doi:10.1096/fj.201901465rrr · Cited by 20
The senescence-associated secretory phenotype in ovarian cancer dissemination
Veenstra, J. P., Bittencourt, L. F. F., & Aird, K. M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00049.2022 · Cited by 21
Self-citationLoss of p16: A Bouncer of the Immunological Surveillance?
Leon, K. E., Tangudu, N. K., Aird, K. M., & Buj, R. (2021) · Life · doi:10.3390/life11040309 · Cited by 22
Self-citationPotential role of cellular senescence in pulmonary arterial hypertension
Liu, L., Wei, Y., Giunta, S., He, Q., & Xia, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13696 · Cited by 21
Serebrenik, A. A., Verduyn, C. W., & Kaytor, M. D. (2022) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1188 · Cited by 20
Cellular senescence in renal ischemia-reperfusion injury
Chen, Y., & Li, Y. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003698 · Cited by 22
Yang, S., Ye, Z., Wang, Z., & Wang, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4801 · Cited by 17
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Metadata
- Authors
- Aird, K. M., Iwasaki, O., Kossenkov, A. V., Tanizawa, H., Fatkhutdinov, N., Bitler, B. G., Le, L., Alicea, G., Yang, T.-L., Johnson, F. B., Noma, K.-I., & Zhang, R.
- Affiliations
- The Wistar Institute (US)
- University of Pennsylvania (US)
- Corresponding author
- Zhang, Rugang
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2016-10-31
- Volume
- 215
- Issue
- 3
- Pages
- 325-334
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC5100296
- OpenAlex
- W2540036007
- Cited by
- 175
- References
- 36
- Citations by year
- 2026: 20 · 2025: 13 · 2024: 18 · 2023: 18 · 2022: 20 · 2021: 21 · 2020: 16 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 2
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- zvestiya of the National Academy of Sciences of Belarus (National Academy of Sciences of Belarus) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA160331, R01CA163377, R01CA202919, K99CA194309, K99CA194318)
- Ovarian Cancer Research Fund
- W.W. Smith Charitable Trust (C1501)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- HMGB2, cellular senescence, senescence-associated secretory phenotype, senescence-associated heterochromatin foci, heterochromatin spreading, chromatin landscape, gene silencing, transcriptional regulation
- MeSH terms
- Cell Line, Chromatin, Gene Expression Regulation, Heterochromatin, Humans, Phenotype, Protein Binding, Cellular Senescence, HMGB2 Protein, Secretory Pathway, Genetic Loci, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.